IMNN - Imunon, Inc.
3.24
-0.100 -3.086%
Share volume: 19,382
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$3.34
-0.10
-0.03%
Summary score
42%
Profitability
43%
Dept financing
33%
Liquidity
58%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-21.14%
Return on assets
-26.3%
Return on sales
-4865.99%
Return on invested capital
76.52%
Total debt ratio
43.56%
Debt ratio change over timeo
-1.37%
Current Ratio
3.54%
Quick Ratio
5.15%
Cash Position Ratio
3.01%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-43.31%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
68.51%
Debt ratio change over timeo
0%
Current Ratio
1.39%
Quick Ratio
0%
Cash Position Ratio
0.97%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-38.67%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
54.59%
Debt ratio change over time
0%
Current Ratio
1.73%
Quick Ratio
0%
Cash Position Ratio
1.25%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-74.82%
Return on assets
-88.79%
Return on sales
11544.08%
Return on invested capital
-101.59%
Total debt ratio
-137.32%
Debt ratio change over time
-1.37%
Current Ratio
-9.23%
Quick Ratio
-9.23%
Cash Position Ratio
-8.75%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IMNN | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -21.14% | 13.23% | 9.84% | 26.17% |
| Return on assets | -26.3% | 4.59% | 3.2% | 1.81% |
| Return on sales | -4865.99% | 30.04% | 25.15% | 24.65% |
| Return on invested capital | 76.52% | 8.51% | 10.28% | 4.83% |
| Profitability | 25% | 65% | 51% | 57% |
| Total debt ratio | 43.56% | 80.7% | 59.39% | 93.28% |
| Debt ratio change over time | -1.37% | -16.59% | -73.52% | 21.11% |
| Dept financing | 12% | 22% | 16% | 50% |
| Current Ratio | 1.39% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 0.97% | 0.14% | 0.46% | 0.15% |
| Liquididy | 75% | 14% | 17% | 12% |
| Short-term ratios | IMNN | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -43.31% | 5.82% | 4.08% | 0.78% |
| Return on sales | 0% | 38.27% | 25.36% | 15.48% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 13% |
| Total debt ratio | 68.51% | 81.38% | 59.57% | 99.65% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 42% | 20% | 15% | 25% |
| Current Ratio | 1.39% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 0.97% | 0.14% | 0.46% | 0.15% |
| Liquididy | 50% | 53% | 52% | 31% |